U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H6N2O
Molecular Weight 74.0818
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLYCINAMIDE

SMILES

NCC(N)=O

InChI

InChIKey=BEBCJVAWIBVWNZ-UHFFFAOYSA-N
InChI=1S/C2H6N2O/c3-1-2(4)5/h1,3H2,(H2,4,5)

HIDE SMILES / InChI

Molecular Formula C2H6N2O
Molecular Weight 74.0818
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Preparation of Fab' from murine IgG2a for thiol reactive conjugation.
2001
Gemcitabine and pemetrexed disodium combinations in vitro and in vivo.
2001 Dec
Involvement of a transformylase enzyme in siderophore synthesis in Pseudomonas aeruginosa.
2001 Jun
A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability.
2001 Mar 1
Pemetrexed disodium (Eli Lilly).
2001 Nov
Proton transfer dynamics of GART: the pH-dependent catalytic mechanism examined by electrostatic calculations.
2001 Nov
Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase.
2001 Nov 13
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck.
2001 Sep 1
Sequence dependence of Alimta (LY231514, MTA) combined with doxorubicin in ZR-75-1 human breast carcinoma cells.
2001 Sep-Oct
10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.
2002 Aug
The pemetrexed/gemcitabine combination in pancreatic cancer.
2002 Aug 15
Pemetrexed safety and dosing strategy.
2002 Dec
Molecular, biochemical, and cellular pharmacology of pemetrexed.
2002 Dec
Crystal structures of human GAR Tfase at low and high pH and with substrate beta-GAR.
2002 Dec 3
Biochemical and structural characterization of the cross-linked complex of nitrogenase: comparison to the ADP-AlF4(-)-stabilized structure.
2002 Dec 31
Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.
2002 Jan 7
Synthesis of a new antischistosomally active and toxicologically tolerant C-12 monothione surrogate of the universal antihelmintic praziquantel.
2002 Jul-Aug
Pemetrexed: translational research in breast cancer.
2002 Jun
PurT-encoded glycinamide ribonucleotide transformylase. Accommodation of adenosine nucleotide analogs within the active site.
2002 Jun 28
New N(3)S donor ligand small peptide analogues of the N-mercaptoacetyl-glycylglycylglycine ligand in the clinically used Tc-99m renal imaging agent: evidence for unusual amide oxygen coordination by two new ligands.
2002 Jun 3
Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163.
2002 Oct
Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type.
2002 Oct
Antifolates targeting purine synthesis allow entry of tumor cells into S phase regardless of p53 function.
2002 Sep 15
Chemically modified "polar patch" mutants of subtilisin in peptide synthesis with remarkably broad substrate acceptance: designing combinatorial biocatalysts.
2002 Sep 16
Practical asymmetric synthesis of vicinal diamines through the catalytic highly enantioselective alkylation of glycine amide derivatives.
2003
Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells.
2003 Aug
Tomoregulin ectodomain shedding by proinflammatory cytokines.
2003 Aug 15
A defect in the p53 response pathway induced by de novo purine synthesis inhibition.
2003 Dec 5
Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.
2003 Feb 13
LY309887, antifolate via the folate receptor suppresses murine type II collagen-induced arthritis.
2003 Nov-Dec
10-(2-benzoxazolcarbonyl)-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid: a potential inhibitor of GAR transformylase and AICAR transformylase.
2003 Oct 1
FDA drug approval summaries: pemetrexed (Alimta).
2004
The crystal structure of the hydrolase domain of 10-formyltetrahydrofolate dehydrogenase: mechanism of hydrolysis and its interplay with the dehydrogenase domain.
2004 Apr 2
BMS-201620: a selective beta 3 agonist.
2004 Jul 5
Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent.
2004 Jun 15
Basal jawed vertebrate phylogeny inferred from multiple nuclear DNA-coded genes.
2004 Mar 11
Kinetic and mechanistic investigation of the selective acidolysis of the C-terminal amide bond of N-acyl-N,alpha,alpha-trialkyl glycine amides.
2005 Jul
Application of intramolecular 1,3-dipolar cyclic addition of azide and olefin; construction of (pyrrolidine-2-ylidene)glycinate and glycinamides.
2005 May
Design, synthesis, and biological evaluation of 10-methanesulfonyl-DDACTHF, 10-methanesulfonyl-5-DACTHF, and 10-methylthio-DDACTHF as potent inhibitors of GAR Tfase and the de novo purine biosynthetic pathway.
2005 May 16
Patents
Substance Class Chemical
Created
by admin
on Thu Jul 06 01:25:14 UTC 2023
Edited
by admin
on Thu Jul 06 01:25:14 UTC 2023
Record UNII
4JDT453NWO
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLYCINAMIDE
Systematic Name English
GLYCINE AMIDE
Common Name English
AMINOACETAMIDE
Systematic Name English
2-AMINOACETAMIDE
Systematic Name English
ACETAMIDE, 2-AMINO-
Systematic Name English
Code System Code Type Description
CAS
598-41-4
Created by admin on Thu Jul 06 01:25:14 UTC 2023 , Edited by admin on Thu Jul 06 01:25:14 UTC 2023
PRIMARY
CHEBI
42843
Created by admin on Thu Jul 06 01:25:14 UTC 2023 , Edited by admin on Thu Jul 06 01:25:14 UTC 2023
PRIMARY
EPA CompTox
DTXSID1060508
Created by admin on Thu Jul 06 01:25:14 UTC 2023 , Edited by admin on Thu Jul 06 01:25:14 UTC 2023
PRIMARY
DRUG BANK
DB03636
Created by admin on Thu Jul 06 01:25:14 UTC 2023 , Edited by admin on Thu Jul 06 01:25:14 UTC 2023
PRIMARY
ECHA (EC/EINECS)
209-932-4
Created by admin on Thu Jul 06 01:25:14 UTC 2023 , Edited by admin on Thu Jul 06 01:25:14 UTC 2023
PRIMARY
FDA UNII
4JDT453NWO
Created by admin on Thu Jul 06 01:25:14 UTC 2023 , Edited by admin on Thu Jul 06 01:25:14 UTC 2023
PRIMARY
WIKIPEDIA
Glycinamide
Created by admin on Thu Jul 06 01:25:14 UTC 2023 , Edited by admin on Thu Jul 06 01:25:14 UTC 2023
PRIMARY
PUBCHEM
69020
Created by admin on Thu Jul 06 01:25:14 UTC 2023 , Edited by admin on Thu Jul 06 01:25:14 UTC 2023
PRIMARY
MESH
C018556
Created by admin on Thu Jul 06 01:25:14 UTC 2023 , Edited by admin on Thu Jul 06 01:25:14 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> METABOLITE ACTIVE